Average life expectancy in developed countries is approximately 80 years. A large proportion of our energy is devoted to the protection of the organism against harmful environmental influences, stress and radiation. Because of this permanent drain on energy, our genetic structure changes, a situation which then accelerates the aging process. As a result of this, our life expectancy can be reduced by up to 40%.

Our current scientific capabilities allow us to control the aging process using peptides that influence the organism’s bioregulation system. These peptides possess remarkable tissue-specific properties and exert positive effects on the organs from which they are extracted. They play an important role in the exchange of information between cells of the immune, nervous and endocrine systems, in the reconstruction of organs and tissues, in functional regeneration, and in the regulation of gene activity. During this process these short peptides become bound to precisely defined sites in the genes before these data-containing structures within the DNA molecules are transcribed.

Professor Khavinson, a world-renowned gerontologist at the University of St. Petersburg who specializes in bioregulation and gerontology, was the first scientist to produce these peptides in a natural way. His innovative and highly effective technology has enabled the extraction these peptides from the tissues of young animals. Since the peptide bioregulators are not converted within the digestive system, they are highly compatible for everyone. No side effects have been observed, since the peptides are proteins which are also produced by the human body and which are therefore not treated as alien. Because of their small size, they act very rapidly and are considered inimitable due to their extraordinary and unique effect. Approximately 15 million people have used them in recent years, and feedback has been 100% positive.

As we get older, a peptide deficiency develops along with restricted protein synthesis, so that wear occurs in both the individual tissues and the whole organism. This then accelerates the aging process. To ensure that all cells can operate without any limitations, a certain quantity of peptides is required to maintain gene function at an optimal level. Peptides that are active in particular cells are also synthesized by these cells. Along with general performance of the body’s cells, peptide production also decreases with old age, which in turn has a negative effect on cell function. This results in a progression of tissue degeneration. The use of short peptides is therefore one of the most important innovations in modern medicine. By stimulating the proliferation and regeneration of tissues and increasing the cell count, the aging process can be decelerated by up to 40%.

A next significant and unique benefit is the anti-tumor effect within the body which arises from the contribution of peptides towards cellular regeneration and the harmonization of cyclic processes. The use of peptides is currently seen as a truly uncompromising solution for the prevention of tumor disease. At the same time the capacity for tissue-regenerating, regular cell division is also increased, which has a positive effect on the body as well.

This means that these peptides are identical in both animals and humans. Their capacity to normalize protein synthesis was proven long ago. We also know that the cell takes up no more peptides than it actually needs. The natural peptides act uniformly, because the tissue only provides feedback once enough peptides have accumulated to compensate for any existing deficiency. Only then do the cells return to a normal function.
Quelle: http://peptide-bioregulator.com/bioregulator/de/peptide-bioregulatoren/

Slider BildThis procedure has been scientifically proven to extend a person’s life. Many people in the US alone required cell therapy in 2000: for patients with cardiovascular disease – estimated at 5,800,000 individuals, autoimmune diseases – 30,000,000 people, diabetes mellitus – 12,000,000 people, osteoporosis – 10,000,000 people, oncological pathologies – 8 200,000 people, Alzheimer’s disease – 5,500,000 people, Parkinson’s disease – 5,500,000 individuals, severe burns – 300,000 people, spinal cord damage – 250,000 people, and malformations – 150,000 people. Slider BildSimilar findings have also been observed in other countries. The use of a complex of peptide bioregulators greatly reduces the risk of even becoming included under these statistics.
Quelle:http://epitalon-info.net/dossier-epithalon-professor-vladimir-khavinson/